# Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

> **NCT01602367** · PHASE2 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 7 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** Placebo matching with BMS-823778

## Key facts

- **NCT ID:** NCT01602367
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2015-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01602367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01602367, "Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01602367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*